Last year the GCC lagged behind global emerging markets. Now, the region is in the spotlight after outperforming the MSCI emerging market index and attracting growing amounts of foreign capital. Julian Evans reports.
It’s a company you may never have heard of, but Russia’s Human Stem Cell Institute wants to reopen the country’s IPO market and become a global biotech player. Founder Artur Isaev tells Tim Burke how he plans to do it.